IP Library › Granted Patent US 12,410,410
Granted Patent B2
US 12,410,410 · App. 17/553,455 · Granted Sep 9, 2025

Ketoreductase polypeptides for the synthesis of chiral compounds

Inventors: Oscar Alvizo (Fremont, CA); Nicholas J. Agard (San Francisco, CA); Xinkai Xie (Castro Valley, CA); David Entwistle (San Carlos, CA); Birgit Kosjek (Westfield, NJ)
Assignee: Codexis, Inc.
C12N9/0006C12P7/02C12P7/40C12P17/12C12P41/002C12Y101/01184
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,410,410
App. No.
17/553,455
Granted
Sep 9, 2025
Kind
B2
Abstract

The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds.

Claims (38)

1. An engineered polypeptide comprising an amino acid sequence with at least 95% sequence identity to SEQ ID NO: 240, wherein the residue corresponding to X150 is a tryptophan, the residue corresponding to X173 is a non-polar or aliphatic residue, the residue corresponding to X211 is an aromatic, acidic, or polar residue, and wherein the residue corresponding to X249 is glycine and wherein said polypeptide has ketoreductase activity with at least 2-fold greater selectivity to the chiral compound 2a relative to chiral compound 2c as compared to SEQ ID NO:2.

2. The engineered polypeptide of claim 1 , wherein said amino acid sequence further comprises at least one of the following:

the residue corresponding to X68 is a non-polar, or aliphatic residue;

the residue corresponding to X94 is a polar, or non-polar residue;

the residue corresponding to X102 is an acidic residue;

the residue corresponding to X110 is an acidic, or aromatic residue;

the residue corresponding to X114 is a non-polar residue;

the residue corresponding to X135 is a basic residue;

the residue corresponding to X144 is a non-polar, or aromatic residue;

the residue corresponding to X145 is an aromatic residue;

the residue corresponding to X147 is a non-polar, or aliphatic residue;

the residue corresponding to X149 is a polar residue;

the residue corresponding to X153 is a polar, or aromatic residue;

the residue corresponding to X158 is a non-polar, or aliphatic residue;

the residue corresponding to X175 is a polar residue;

the residue corresponding to X190 is an aromatic, aliphatic, non-polar, or polar residue;

the residue corresponding to X196 is an aromatic, polar, basic, non-polar, or aliphatic residue;

the residue corresponding to X197 is an aromatic residue;

the residue corresponding to X198 is a non-polar, polar residue;

the residue corresponding to X199 is an acidic residue;

the residue corresponding to X201 is a polar residue;

the residue corresponding to X202 is an aromatic, or basic residue;

the residue corresponding to X203 is an aromatic, non-polar, or aliphatic residue;

the residue corresponding to X205 is a polar residue;

the residue corresponding to X206 is an aromatic residue;

the residue corresponding to X207 is an aromatic, acidic, non-polar, or aliphatic residue;

the residue corresponding to X209 is an aromatic, acidic, non-polar, polar, or aliphatic residue;

the residue corresponding to X210 is a non-polar, or aliphatic residue;

the residue corresponding to X212 is an aromatic, basic, non-polar, aliphatic, or acidic residue;

the residue corresponding to X213 is an aromatic, basic, acidic, polar, non-polar, or aliphatic residue;

the residue corresponding to X217 is a polar, or aromatic residue;

the residue corresponding to X233 is a polar residue;

the residue corresponding to X250 is a non-polar residue; and

the residue corresponding to X252 is an aromatic residue.

3. The engineered polypeptide of claim 1 , comprising at least one substitution selected from X68V, X94G/M/Q, X102D, X110E/W, X114G, X135K, X144G/W, X145W, X147L, X149S, X153H/P/T/V/C, X158V, X173L, X175T, X196H/I/K/N/Q, X196I, X196K/N/Q, X197Y, X198G/S, X199E, X201N, X202F/H/R/Y, X203G/L/W, X205T, X206H/W/Y, X207D/G/V/Y, X209E/F/G/I/M/T/V/W, X210L/P, X211E/H/P/S, X212A/E/G/H/N/P/R/V, X213D/E/G/H/K/M/N/R, X217H/N, X233Q/T, X250G, and X252W.

4. The engineered polypeptide of claim 1 , comprising a substitution at position X190 as compared to SEQ ID NO: 2.

5. The engineered polypeptide of claim 4 , wherein the substitution at position X190 is selected from P, A, T, or Q.

6. An engineered polypeptide of claim 1 having ketoreductase activity, wherein the polypeptide comprises SEQ ID NO: 240.

Assignments (2)
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2024
From: ALVIZO, OSCAR; AGARD, NICHOLAS; ENTWISTLE, DAVID; XIE, XINKAI; KOSJEK, BIRGIT; MERCK SHARPE & DOHME CORP; MERCK SHARPE & DOHME CORP
To: CODEXIS, INC.
Reel/Frame 066418/0806 →
Continuity (4)
Continuation 16874574 · May 14, 2020
Division 15543535
Provisional Application 62114380 · Feb 10, 2015
Related Publication 20220106575A1 · Apr 7, 2022
References Cited (182)
US 5538867A · Durliat et al. · 1996 [cited by applicant]
US 5559030A · Matsuyama et al. · 1996 [cited by applicant]
US 5605793A · Stemmer · 1997 [cited by applicant]
US 5700670A · Yamagishi et al. · 1997 [cited by applicant]
US 5811238A · Stemmer et al. · 1998 [cited by applicant]
US 5830721A · Stemmer et al. · 1998 [cited by applicant]
US 5834252A · Stemmer et al. · 1998 [cited by applicant]
US 5837458A · Minshull et al. · 1998 [cited by applicant]
US 5891685A · Yamagishi et al. · 1999 [cited by applicant]
US 5928905A · Stemmer et al. · 1999 [cited by applicant]
US 6096548A · Stemmer · 2000 [cited by applicant]
US 6117679A · Stemmer · 2000 [cited by applicant]
US 6132970A · Stemmer · 2000 [cited by applicant]
US 6165793A · Stemmer · 2000 [cited by applicant]
US 6180406B1 · Stemmer · 2001 [cited by applicant]
US 6251674B1 · Tobin et al. · 2001 [cited by applicant]
US 6277638B1 · Stemmer · 2001 [cited by applicant]
US 6287861B1 · Stemmer et al. · 2001 [cited by applicant]
US 6287862B1 · delCardayre et al. · 2001 [cited by applicant]
US 6291242B1 · Stemmer · 2001 [cited by applicant]
US 6297053B1 · Stemmer · 2001 [cited by applicant]
US 6303344B1 · Patten et al. · 2001 [cited by applicant]
US 6309883B1 · Minshull et al. · 2001 [cited by applicant]
US 6319713B1 · Patten et al. · 2001 [cited by applicant]
US 6319714B1 · Crameri et al. · 2001 [cited by applicant]
US 6323030B1 · Stemmer · 2001 [cited by applicant]
US 6326204B1 · delCardayre et al. · 2001 [cited by applicant]
US 6335160B1 · Patten et al. · 2002 [cited by applicant]
US 6335198B1 · delCardayre et al. · 2002 [cited by applicant]
US 6344356B1 · Stemmer · 2002 [cited by applicant]
US 6352859B1 · delCardayre et al. · 2002 [cited by applicant]
US 6355484B1 · Patten et al. · 2002 [cited by applicant]
US 6358740B1 · Patten et al. · 2002 [cited by applicant]
US 6358742B1 · Stemmer · 2002 [cited by applicant]
US 6365377B1 · Patten et al. · 2002 [cited by applicant]
US 6365408B1 · Stemmer · 2002 [cited by applicant]
US 6368861B1 · Crameri et al. · 2002 [cited by applicant]
US 6372497B1 · Stemmer · 2002 [cited by applicant]
US 6376246B1 · Crameri et al. · 2002 [cited by applicant]
US 6379964B1 · delCardayre et al. · 2002 [cited by applicant]
US 6387702B1 · Stemmer · 2002 [cited by applicant]
US 6391552B2 · Stemmer · 2002 [cited by applicant]
US 6391640B1 · Minshull et al. · 2002 [cited by applicant]
US 6395547B1 · Stemmer · 2002 [cited by applicant]
US 6399339B1 · Wolberg et al. · 2002 [cited by applicant]
US 6406855B1 · Patten et al. · 2002 [cited by applicant]
US 6406910B1 · Patten et al. · 2002 [cited by applicant]
US 6413745B1 · Patten et al. · 2002 [cited by applicant]
US 6413774B1 · Stemmer · 2002 [cited by applicant]
US 6420175B1 · Stemmer · 2002 [cited by applicant]
US 6423542B1 · Crameri et al. · 2002 [cited by applicant]
US 6426224B1 · Crameri et al. · 2002 [cited by applicant]
US 6436675B1 · Welch et al. · 2002 [cited by applicant]
US 6444468B1 · Stemmer et al. · 2002 [cited by applicant]
US 6479652B1 · Crameri et al. · 2002 [cited by applicant]
US 6482647B1 · Stemmer · 2002 [cited by applicant]
US 6489146B2 · Stemmer et al. · 2002 [cited by applicant]
US 6495023B1 · Zeikus et al. · 2002 [cited by applicant]
US 6506602B1 · Stemmer · 2003 [cited by applicant]
US 6506603B1 · Stemmer · 2003 [cited by applicant]
US 6519065B1 · Colbourne et al. · 2003 [cited by applicant]
US 6521453B1 · Crameri et al. · 2003 [cited by applicant]
US 6528311B1 · delCardayre et al. · 2003 [cited by applicant]
US 6573098B1 · Stemmer · 2003 [cited by applicant]
US 6576467B1 · Stemmer · 2003 [cited by applicant]
US 6579678B1 · Patten et al. · 2003 [cited by applicant]
US 6586182B1 · Patten et al. · 2003 [cited by applicant]
US 6602986B1 · Stemmer et al. · 2003 [cited by applicant]
US 6613514B2 · Patten et al. · 2003 [cited by applicant]
US 6645746B1 · Kizaki et al. · 2003 [cited by applicant]
US 6653072B1 · Patten et al. · 2003 [cited by applicant]
US 6716631B1 · delCardayre et al. · 2004 [cited by applicant]
US 6800477B2 · Patel et al. · 2004 [cited by applicant]
US 6946296B2 · Patten et al. · 2005 [cited by applicant]
US 6961664B2 · Selifonov et al. · 2005 [cited by applicant]
US 6995017B1 · Stemmer · 2006 [cited by applicant]
US 7024312B1 · Selifonov et al. · 2006 [cited by applicant]
US 7058515B1 · Selifonov et al. · 2006 [cited by applicant]
US 7105297B2 · Minshull et al. · 2006 [cited by applicant]
US 7148054B2 · delCardayre et al. · 2006 [cited by applicant]
US 7288375B2 · Stemmer et al. · 2007 [cited by applicant]
US 7421347B2 · Selifonov et al. · 2008 [cited by applicant]
US 7430477B2 · Selifonov et al. · 2008 [cited by applicant]
US 7534564B2 · Patten et al. · 2009 [cited by applicant]
US 7620500B2 · Mundorff et al. · 2009 [cited by applicant]
US 7620502B2 · Selifonov et al. · 2009 [cited by applicant]
US 7629170B2 · delCardayre et al. · 2009 [cited by applicant]
US 7702464B1 · Emig et al. · 2010 [cited by applicant]
US 7747391B2 · Gustafsson et al. · 2010 [cited by applicant]
US 7747393B2 · Fox · 2010 [cited by applicant]
US 7751986B2 · Gustafsson et al. · 2010 [cited by applicant]
US 7776598B2 · Patten et al. · 2010 [cited by applicant]
US 7783428B2 · Gustafsson et al. · 2010 [cited by applicant]
US 7795030B2 · Minshull et al. · 2010 [cited by applicant]
US 7853410B2 · Selifonov et al. · 2010 [cited by applicant]
US 7868138B2 · Stemmer et al. · 2011 [cited by applicant]
US 7873499B2 · Selifonov et al. · 2011 [cited by applicant]
US 7883879B2 · Campopiano et al. · 2011 [cited by applicant]
US 7904249B2 · Selifonov et al. · 2011 [cited by applicant]
US 7957912B2 · Selifonov et al. · 2011 [cited by applicant]
US 7977078B2 · Liang · 2011 [cited by examiner]
US 8748143B2 · Liang et al. · 2014 [cited by applicant]
US 10696953B2 · Alvizo et al. · 2020 [cited by applicant]
US 20050095619A1 · Davis et al. · 2005 [cited by applicant]
US 20050153417A1 · Davis et al. · 2005 [cited by applicant]
US 20060195947A1 · Davis et al. · 2006 [cited by applicant]
US 20060286646A1 · Patel et al. · 2006 [cited by applicant]
US 20080220990A1 · Fox · 2008 [cited by applicant]
US 20090191605A1 · Liang et al. · 2009 [cited by applicant]
US 20090312196A1 · Colbeck et al. · 2009 [cited by applicant]
US 20110159567A1 · Campopiano et al. · 2011 [cited by applicant]
WO 9522625A1 · 1995 [cited by applicant]
WO 9533836A1 · 1995 [cited by applicant]
WO 9600787A1 · 1996 [cited by applicant]
WO 970078A1 · 1997 [cited by applicant]
WO 9735966A1 · 1997 [cited by applicant]
WO 9827230A1 · 1998 [cited by applicant]
WO 200042651A1 · 2000 [cited by applicant]
WO 2000053731A2 · 2000 [cited by applicant]
WO 2001040450A1 · 2001 [cited by applicant]
WO 200175767A2 · 2001 [cited by applicant]
WO 2005018579A2 · 2005 [cited by applicant]
WO 2005054491A1 · 2005 [cited by applicant]
WO 2008042876A2 · 2008 [cited by applicant]
WO 2009036404A2 · 2009 [cited by applicant]
WO 2009152336A1 · 2009 [cited by applicant]
WO 2013074650A1 · 2013 [cited by applicant]
WO 2014188353A2 · 2014 [cited by applicant]
WO 2016130412A1 · 2016 [cited by applicant]
UniProtKB/Swiss-Prot No. P14941 dated May 10, 2017. [cited by applicant]
Grau, B.T., et al., “Chemo- and Enantioselective Routes to Chiral Fluorinated Hydroxyketones Using Ketoreductases,” Organic Letters, 9(24):4951-4954 [2007]. [cited by applicant]
Ngo, J.T., et al., “Computational Complexity, Protein Structure Prediction and the Levinthal Paradox” in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 … [cited by applicant]
Altschul, S., et al., “Basic local alignment search tool,” J. Mol. Biol., 215: 403-410 (1990). [cited by applicant]
Altschul, S.F., et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Res., 25(17):3389-3402 (1997). [cited by applicant]
Botstein, D., et al., “Strategies and applications of in vitro mutagenesis,” Science, 229(4719):1193-1201, 1985. [cited by applicant]
Broussy, R.W., et al., “Enantioselective, Ketoreductase-Based Entry into Pharmaceutical Building Blocks: Ethanol as Tunable Nicotinamide Reductant,” Org. Lett., 11(2):305-308 [2009]. [cited by applicant]
Carter, P., “Site-directed mutagenesis,” Biochem. J., 237:1-7 (1986). [cited by applicant]
Christians, F.C., et al., “Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling,” Nat. Biotechnol., 17:259-264 (1999). [cited by applicant]
Crameri, A., et al., “DNA shuffling of a family of genes from diverse species accelerates directed evolution,” Nature, 391:288-291 (1998). [cited by applicant]
Crameri, A., et al., “Improved green fluorescent protein by molecular evolution using DNA shuffling,” Nat. Biotechnol., 14(3):315-319 (1996). [cited by applicant]
Crameri, A., et al., “Molecular evolution of an arsenate detoxification pathway by DNA shuffling,” Nat. Biotechnol., 15(5):436-438 (1997). [cited by applicant]
Dale, S.J., et al., “Oligonucleotide-directed random mutagenesis using the phosphorothioate method,” Methods Mol. Biol., 57:369-74 (1996). [cited by applicant]
De Boer, H.A., et al., “The tac promoter: A functional hybrid derived from the trp and lac promoters,” Proc. Natl Acad. Sci. USA, 80: 21-25 (1983). [cited by applicant]
Ehrlich, S.D.,“DNA cloning in Bacillus subtilis,” Proc. Natl. Acad. Sci. USA, 75(3):1433-1436 [1978]. [cited by applicant]
Guo, Z., et al., “3′-End-Forming Signals of Yeast mRNA,” Mol. Cell. Biol., 15(11):5983-5990 [1995]. [cited by applicant]
Heilmann, H.J., et al., “Identification and isolation of glucose dehydrogenase genes of Bacillus megaterium M1286 and their expression in Escherichia coli,” Eur. J. Biochem., 174:485-490 [1988]. [cited by applicant]
Henikoff, S.,et al., “Amino acid substitution matrices from protein blocks,” Proc. Natl. Acad. Sci., 89:10915-10919 (1992). [cited by applicant]
Hummel, W., et al., “Dehydrogenases for the synthesis of chiral compounds,” Eur. J. Biochem., 184:1-13 [1989]. [cited by applicant]
Vanova, N., et al., “Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis,” Nature, 123:87-91 [2003]. [cited by applicant]
Kramer, B., et al., “Different base/base mismatches are corrected with different efficiencies by the methyl-directed DNA mismatch-repair system of [cited by applicant]
Lampel, K.A., et al., “Characterization of the developmentally regulated Bacillus subtilis glucose dehydrogenase gene,” J. Bacteriol., 166:238-243 [1986]. [cited by applicant]
Lathe, R., et al., “Plasmid and bacteriophage vectors fir excision of intact inserts,” Gene, 57:193-201 [1987]. [cited by applicant]
Ling, M., et al., “Approaches to DNA Mutagenesis: An Overview,” Anal. Biochem., 254:157-78 (1997). [cited by applicant]
Matthes, H.W.D., et al., “Simultaneous rapid chemical synthesis of over one hundred oligonucleotides on a microscale,” EMBO J., 3(4):801-05 (1984). [cited by applicant]
Minshull, J., et al., “Protein evolution by molecular breeding,” Curr. Op. Chem. Biol., 3(3):284-290 (1999). [cited by applicant]
Mitamura, T., et al., “Structure of isozyme genes of glucose dehydrogenase from Bacillus megaterium IAM1030,” J. Ferment. Bioeng., 70:363-369 [1990]. [cited by applicant]
Needleman, S., et al., “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” J. Mol. Biol. 48:443-453 (1970). [cited by applicant]
Pearson, W.R., “Improved tools for biological sequence comparison,” Proc. Nat'l. Acad. Sci. USA, 85:2444-2448 (1988). [cited by applicant]
Romanos, M.A., et al., “Foreign gene expression in yeast: a review,” Yeast 8:423-488 [1992]. [cited by applicant]
Santaniello, E., et al., “Chiral synthesis of a component of Amanita muscaria, (−)-4-hydroxypyrrolidin-2-one, and Assessment of its absolute configuration,” J. Chem. Res., (S)132-133 [1984]. [cited by applicant]
Simonen, M., et al., “Protein Secretion in [cited by applicant]
Smith, M., “In vitro mutagenesis,” Ann. Rev. Genet., 19:423-462 (1985). [cited by applicant]
Smith, T., et al., “Comparison of Biosequences,” Adv. Appl. Math, 2:482-489 (1981). [cited by applicant]
Stellwagon, E., “Dye Affinity Chromatography,” Current Protocols in Protein Science, Unit 9.2-9.2.16 [2001]. [cited by applicant]
Stemmer, W., “DNA Shuffling by Random Fragmentation and Reassembly: In vitro Recombination for Molecular Evolution,” Proc. Natl. Acad. Sci. USA, 91:10747-10751 (1994). [cited by applicant]
Stemmer, W.P.C., “Rapid evolution of a protein in vitro by DNA shuffling”, Nature, 370:389-391 (1994). [cited by applicant]
Vasantha, N., et al., “Isolation of a developmental gene of Bacillus subtilis and its expression in [cited by applicant]
Villa-Komaroff, L., et al., “A bacterial clone synthesizing proinsulin,” Proc. Natl Acad. Sci. USA, 75:3727-3731 (1978). [cited by applicant]
Wells, J.A., et al., “Cassette mutagenesis: an efficient method for generation of multiple mutations at defined sites,” Gene, 34:315-323 (1985). [cited by applicant]
Yamane, K., et al., “The 25°-36° region of the Bacillus subtilis chromosome: determination of the sequence of a 146 kb segment and identification of 113 genes ,” Microbiology, 142(11):3047-3056 [1996]. [cited by applicant]
Zhang, J-H., et al., “Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening ,” Proc. Nat. Acad. Sci., U.S.A., 94:4504-4509 (1997). [cited by applicant]
Zhou, B., et al., “Stereochemical control of yeast reductions. 1. Asymmetric synthesis of L-Carnitine,” J. Am. Chem. Soc., 105:5925-5926 [1983]. [cited by applicant]
4-Chloro-6,7dihydro-5H-cyclopenta[b]pyridine-7-ol, CRST Pharmatech [2016]; retrieved from http://www.crstpharma.com. [cited by applicant]
Genbank Accession No. 1NXQ_A dated Sep. 24, 2008. [cited by applicant]
Genbank Accession No. AAP94029.1 dated Apr. 1, 2004. [cited by applicant]
Genbank Accession No. AE017013 dated May 16, 2003. [cited by applicant]
Genbank Accession No. AF160799 dated Dec. 9, 1999. [cited by applicant]
Genbank Accession No. BAA24528.1 dated Jan. 28, 1998. [cited by applicant]
Genbank Accession No. D50453 dated Jul. 6, 2007. [cited by applicant]
Genbank Accession No. JC7338 dated Jun. 3, 2002. [cited by applicant]
Genbank Accession No. M12276 dated Apr. 26, 1993. [cited by applicant]
Genbank Accession No. X12370 dated Oct. 23, 2008. [cited by applicant]